Shares of Colgate-Palmolive Company (NYSE:CL) have been assigned a consensus recommendation of “Hold” from the sixteen analysts that are covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $75.22.

Several brokerages recently weighed in on CL. Jefferies Group LLC reaffirmed a “hold” rating and issued a $79.00 price target on shares of Colgate-Palmolive in a research note on Thursday, August 24th. Zacks Investment Research cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Deutsche Bank AG reaffirmed a “hold” rating and issued a $75.00 price target on shares of Colgate-Palmolive in a research note on Monday, July 24th. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research note on Monday, July 24th. Finally, BidaskClub cut Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a research note on Wednesday, July 12th.

In other news, insider Patricia Verduin sold 3,833 shares of the stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $71.45, for a total value of $273,867.85. Following the sale, the insider now directly owns 53,173 shares of the company’s stock, valued at $3,799,210.85. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP John J. Huston sold 14,000 shares of the stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $71.36, for a total value of $999,040.00. Following the completion of the sale, the senior vice president now directly owns 88,598 shares in the company, valued at $6,322,353.28. The disclosure for this sale can be found here. Over the last three months, insiders sold 221,802 shares of company stock worth $15,983,976. Insiders own 1.02% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in the stock. Blue Chip Partners Inc. boosted its position in shares of Colgate-Palmolive by 0.4% during the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock valued at $132,000 after buying an additional 8 shares during the last quarter. Cue Financial Group Inc. boosted its position in shares of Colgate-Palmolive by 0.3% during the second quarter. Cue Financial Group Inc. now owns 4,854 shares of the company’s stock valued at $360,000 after buying an additional 14 shares during the last quarter. Cornerstone Financial Partners LLC boosted its position in shares of Colgate-Palmolive by 0.5% during the second quarter. Cornerstone Financial Partners LLC now owns 3,813 shares of the company’s stock valued at $282,000 after buying an additional 19 shares during the last quarter. M Holdings Securities Inc. boosted its position in shares of Colgate-Palmolive by 0.4% during the first quarter. M Holdings Securities Inc. now owns 5,366 shares of the company’s stock valued at $393,000 after buying an additional 21 shares during the last quarter. Finally, AlphaMark Advisors LLC boosted its position in shares of Colgate-Palmolive by 1.5% during the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after buying an additional 25 shares during the last quarter. 73.16% of the stock is currently owned by institutional investors.

Colgate-Palmolive (NYSE:CL) traded up 0.36% during mid-day trading on Friday, reaching $71.82. 2,952,611 shares of the company traded hands. Colgate-Palmolive has a 12-month low of $63.43 and a 12-month high of $77.27. The stock has a market capitalization of $63.26 billion, a price-to-earnings ratio of 26.69 and a beta of 0.80. The company’s 50-day moving average is $71.66 and its 200-day moving average is $73.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.72. The company had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The firm’s revenue for the quarter was down .5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.70 earnings per share. Equities analysts predict that Colgate-Palmolive will post $2.89 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Colgate-Palmolive Company (CL) Receives Consensus Recommendation of “Hold” from Analysts” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/09/09/colgate-palmolive-company-cl-receives-consensus-recommendation-of-hold-from-analysts.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.